Purification and characterization of insulin-mimetic inositol phosphoglycan-like molecules from grass pea (Lathyrus sativus) seeds

被引:9
作者
Pañeda, C
Villar, AV
Alonso, A
Goñi, FM
Varela, F
Brodbeck, U
León, Y
Varela-Nieto, I
Jones, DR
机构
[1] CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain
[2] Univ Basque Country, Unidad Biofis, CSIC, EHU, E-48080 Bilbao, Spain
[3] Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain
[4] INIA, CRF, Madrid, Spain
[5] Univ Bern, Inst Biochem & Mol Biol, Bern, Switzerland
[6] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain
关键词
D O I
10.1007/BF03401850
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Signal transduction through the hydrolysis of glycosyl-phosphatidylinositol (GPI) leading to the release of the water-soluble inositol phosphoglycan (IPG) molecules has been demonstrated to be important for mediating some of the actions of insulin and insulin-like growth factor-I (IGF-I). Materials and Methods: in the present study, GPI from grass pea (Lathyrus sativus) seeds has been purified and partially characterized on the basis of its chromatographic properties and its compositional analysis. Results: The results indicate that it shows similarities to GPI previously isolated from other sources such as rat liver. IPG was generated from L. sativus seed GPI by hydrolysis with a GPI-specific phospholipase D (GPI-PLD). This IPG inhibited protein kinase A (PKA) in an in vitro assay, caused cell proliferation in explanted cochleovestibular ganglia (CVG), and decreased 8-Br-cAMP-induced phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression in cultured hepatoma cells. Conclusions: Our data indicate that L. sativus seed IPG possess insulin-mimetic activities. This may explain why L. sativus seeds have been used in some traditional medicines to ameliorate diabetic symptoms.
引用
收藏
页码:454 / 460
页数:7
相关论文
共 40 条
[21]  
2-1
[22]   INSULIN-LIKE GROWTH-FACTOR-I REGULATES CELL-PROLIFERATION IN THE DEVELOPING INNER-EAR, ACTIVATING GLYCOSYL-PHOSPHATIDYLINOSITOL HYDROLYSIS AND FOS EXPRESSION [J].
LEON, Y ;
VAZQUEZ, E ;
SANZ, C ;
VEGA, JA ;
MATO, JM ;
GIRALDEZ, F ;
REPRESA, J ;
VARELANIETO, I .
ENDOCRINOLOGY, 1995, 136 (08) :3494-3503
[23]   Involvement of insulin-like growth factor-I in inner ear organogenesis and regeneration [J].
León, Y ;
Sanz, C ;
Frago, LM ;
Camarero, G ;
Cañón, S ;
Varela-Nieto, I ;
Giráldez, F .
HORMONE AND METABOLIC RESEARCH, 1999, 31 (2-3) :126-132
[24]  
Martín-Lomas M, 2000, CHEM-EUR J, V6, P3608, DOI 10.1002/1521-3765(20001002)6:19<3608::AID-CHEM3608>3.0.CO
[25]  
2-Q
[26]  
McConville MJ, 2000, MOL MEMBR BIOL, V17, P1
[27]  
NARAYANAN CR, 1987, CURR SCI INDIA, V56, P139
[28]   A new glycoside, 1D-2-O-alpha-D-galactopyranosyl-chiro-inositol from jojoba beans [J].
Ogawa, K ;
Watanabe, T ;
Ikeda, Y ;
Kondo, S .
CARBOHYDRATE RESEARCH, 1997, 302 (3-4) :219-221
[29]   GLYCOSYL-PHOSPHATIDYLINOSITOL INOSITOL PHOSPHOGLYCAN - A SIGNALING SYSTEM FOR THE LOW-AFFINITY NERVE GROWTH-FACTOR RECEPTOR [J].
REPRESA, J ;
AVILA, MA ;
MINER, C ;
GIRALDEZ, F ;
ROMERO, G ;
CLEMENTE, R ;
MATO, JM ;
VARELANIETO, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (18) :8016-8019
[30]  
RUBENSTEIN AH, 1962, LANCET, V2, P1348